Non-specific low back pain
Conditions
Interventions
experimental group:Loxoprofen sodium cataplasm for external application
control group:Flurbiprofen gel cataplasm
Sponsors
The First People's Hospital of Yunnan Province
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for chronic non-specific low back pain; 2. Patients with obvious pain in the lower back, such as lumbar muscle strain; 3. Aged from 18 to 65 years; 4. No other treatment drugs such as analgesics, hormones, surgical treatment and physical therapy have been taken within 1 month; 5. Subjects voluntarily agree to participate in this study and sign a written informed consent form.
Exclusion criteria
Exclusion criteria: 1. Previously accepted treatments that may affect the curative effect; 2. Back pain caused by lumbar spondylolisthesis, lumbar disc herniation, lumbar spinal stenosis, etc.; 3. There are open wounds, severe osteoporosis, fractures, dislocations, rheumatoid arthritis, etc.; with serious primary diseases such as tumors, cardiovascular, cerebrovascular, and hematological diseases, or with mental illness and communication disorders, the curative effect cannot be determined. Radiating pain or movement disorders caused by other diseases (internal organ diseases, cardiovascular and cerebrovascular diseases); 4. Pregnant and lactating women or women of childbearing age who are about to conceive; 5. Those who have a history of allergies to the drugs used in this study in the past; 6. The investigator thinks it is inappropriate to participate in other situations in this experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate of treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS score;ODI Index;Incidence of adverse drug reactions; | — |
Countries
China
Contacts
Public ContactLu Sheng
The First People's Hospital of Yunnan Province
Outcome results
None listed